JP2025503877A5 - - Google Patents

Info

Publication number
JP2025503877A5
JP2025503877A5 JP2024542107A JP2024542107A JP2025503877A5 JP 2025503877 A5 JP2025503877 A5 JP 2025503877A5 JP 2024542107 A JP2024542107 A JP 2024542107A JP 2024542107 A JP2024542107 A JP 2024542107A JP 2025503877 A5 JP2025503877 A5 JP 2025503877A5
Authority
JP
Japan
Prior art keywords
treprostinil
derivative
pharmaceutically acceptable
acceptable salt
liquid composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024542107A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025503877A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2023/051102 external-priority patent/WO2023139108A1/en
Publication of JP2025503877A publication Critical patent/JP2025503877A/ja
Publication of JP2025503877A5 publication Critical patent/JP2025503877A5/ja
Pending legal-status Critical Current

Links

JP2024542107A 2022-01-21 2023-01-18 肺高血圧症の処置のためのトレプロスチニル Pending JP2025503877A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22152809.4 2022-01-21
EP22152809 2022-01-21
PCT/EP2023/051102 WO2023139108A1 (en) 2022-01-21 2023-01-18 Treprostinil for the treatment of pulmonary hypertension

Publications (2)

Publication Number Publication Date
JP2025503877A JP2025503877A (ja) 2025-02-06
JP2025503877A5 true JP2025503877A5 (https=) 2026-01-26

Family

ID=80113486

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024542107A Pending JP2025503877A (ja) 2022-01-21 2023-01-18 肺高血圧症の処置のためのトレプロスチニル

Country Status (12)

Country Link
US (1) US20250360097A2 (https=)
EP (2) EP4465991A1 (https=)
JP (1) JP2025503877A (https=)
KR (1) KR20240136408A (https=)
CN (1) CN118574627A (https=)
AU (1) AU2023208357A1 (https=)
CA (1) CA3246787A1 (https=)
CL (1) CL2024002193A1 (https=)
IL (1) IL314132A (https=)
MX (1) MX2024008941A (https=)
TW (1) TW202341974A (https=)
WO (1) WO2023139108A1 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2026816B1 (en) 2006-05-15 2018-10-24 United Therapeutics Corporation Treprostinil administration using a metered dose inhaler
GB0800709D0 (en) 2008-01-16 2008-02-20 Dunne Stephen T Double jet impinging nozzle
ES2942417T3 (es) 2017-04-28 2023-06-01 Softhale Nv Dispositivo de inhalación
US12569629B2 (en) * 2020-03-31 2026-03-10 Invox Belgium Nv Inhalation device system

Similar Documents

Publication Publication Date Title
JP5317961B2 (ja) 推進剤を含まないイプラトロピウムブロマイド及びサルブタモールスルフェート含有吸入エアロゾル製剤
JP2009537474A (ja) イプラトロピウムブロマイド及びサルブタモールスルフェートを含有するエアロゾル製剤
WO2021185912A1 (en) Method for the treatment nlrp3-associated diseases
CN113679910A (zh) 雾化装置
ES3039440T3 (en) Compositions comprising remdesivir for use in the treatment of viral diseases
US20220323351A1 (en) Methods of treatment using niclosamide
TWI819055B (zh) 吸入裝置及通過吸入裝置產生氣霧劑的方法
WO2018234527A1 (en) Aerosol delivery of pirfenidone
JP2025503877A5 (https=)
RU2024119713A (ru) Трепростинил для лечения легочной гипертензии
US20210252027A1 (en) Pharmaceutical formulation containing remdesivir
US20250170081A1 (en) Treprostinil for the treatment of pulmonary hypertension
WO2021231361A1 (en) Pharmaceutical formulation containing active metabolites of remdesivir for inhalation
HK40085502B (en) Compositions comprising remdesivir for use in the treatment of viral diseases
HK40085502A (en) Compositions comprising remdesivir for use in the treatment of viral diseases
US20230019058A1 (en) Method for the treatment of viral infections
WO2026057872A1 (en) Inhalable compositions
WO2021262715A1 (en) Pharmaceutical formulation containing active metabolites of remdesivir or its analog for inhalation
TH2711C3 (th) ตำรับยาดมนาโนเมนทอลในระบบนำส่งยาพ่นละอองลอยแบบหัวปั๊ม